Aurora Spine Receives IRB MultiSite Selection Approval for its DEXAC Cervical Interbody System

Carlsbad, Calif., April 04, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB:ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has received Institutional Review Board (IRB) multi-site selection approval for its new multicenter study of DEXA-C™ Cervical Interbody System. The study has selected seven sites with three submitted for approval. After approval, patient enrollment is expected to begin. The study will initially include data from 40 single level and 40 multiple level subjects. The DEXA-C system is indicated for anterior cervical interbody fusion procedures and is…